Jonathan B. Zung

Insider Reports History

Entity
Individual
Location
C/O Evelo Biosciences, Inc., 620 Memorial Drive, Suite 200, Cambridge, MA
Signature
/s/ Diantha Duvall, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan B. Zung:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CURIS INC CDO Employee stock option (right to buy) 40.7K $473K $11.62 May 21, 2024 Direct
Evelo Biosciences, Inc. Chief Development Officer Stock Option (Right to Buy) 115K Jul 19, 2022 Direct

Insider Reports Filed by Jonathan B. Zung

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRIS CURIS INC May 21, 2024 1 $473K 4 May 23, 2024 CDO
CRIS CURIS INC May 1, 2023 1 $415K 4 May 3, 2023 CDO
CRIS CURIS INC May 1, 2023 0 $0 3 May 3, 2023 CDO
EVLO Evelo Biosciences, Inc. Jul 19, 2022 1 $0 4 Oct 14, 2022 Chief Development Officer
EVLO Evelo Biosciences, Inc. Jan 19, 2022 1 $0 4 Jan 21, 2022 Chief Development Officer